Why Imugene, Neuren, Sigma, and Smartgroup shares are charging higher

These shares are ending the week on a high. But why? Let's find out.

| More on:
A man clenches his fists in excitement as gold coins fall from the sky.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a great finish to the week. In afternoon trade, the benchmark index is up 0.9% to 8,299.4 points.

Four ASX shares that are rising more than most are listed below. Here's why they are charging higher:

Imugene Ltd (ASX: IMU)

The Imugene share price is up 4.5% to 4.7 cents. This morning, this clinical-stage immune-oncology company announced the opening of the first Australian site for its azer-cel phase 1b clinical trial. The release notes that the Royal Prince Alfred Hospital in Sydney will begin patient recruitment in November, marking another significant milestone in the development of its promising off-the-shelf allogeneic CAR Tcell therapy.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is up 14% to $16.38. Investors have been buying this pharmaceuticals company's shares since the release of its third quarter update this week. Neuren revealed that Daybue net sales for the last nine months exceeded the full-year threshold of US$250 million for Neuren's first sales milestone income of US$50 million. In addition, third quarter royalty income came in at A$13.2 million, which brings the total to A$37.5 million year to date. Neuren also advised that it expects full year 2024 income to be A$216 million to A$218 million.

Sigma Healthcare Ltd (ASX: SIG)

The Sigma Healthcare share price is up 7% to $2.60. This pharmacy chain operator and wholesale distributor's shares have been on fire this week after the ACCC approved its merger with Chemist Warehouse. Sigma's CEO, Vikesh Ramsunder, said: "The ACCC decision marks a critical milestone for the proposed transaction and provides us with the conviction to progress with the next steps in the process. The proposed transaction has the potential to create a leading ASX listed healthcare company through the combination of the complementary strengths of Sigma's state-of-the-art pharmaceutical distribution infrastructure with Chemist Warehouse Group's retailing know-how."

Smartgroup Corporation Ltd (ASX: SIQ)

The Smartgroup share price is up 4% to $7.98. Investors have been buying this salary packaging and fleet management company's shares following the release of a broker note out of Bell Potter. According to the note, the broker has reaffirmed its buy rating on its shares with an improved price target of $10.00. Bell Potter said: "Traditional volume drivers continue to demonstrate cooling in the broader auto market. Upon closer examination, we view SIQ as reasonable buying at the current levels and review key developments."

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Smartgroup. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

These were the best-performing ASX 200 shares in March 2025

These shares avoided the market selloff and delivered strong returns for their shareholders.

Read more »

Large group of business people listening to their colleague giving them a speech in a board room.
Technology Shares

Wisetech announces key appointment as shares rebound from 52-week low

Has WiseTech finally turned a corner?

Read more »

Man with backpack spreading his arms out and soaking in the sun.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week for ASX investors today.

Read more »

Piggybank with an army helmet and a drone next to it, symbolising a rising DroneShield share price.
ETFs

VanEck Global Defence ETF up 31% since November as defence spending ramps up

As most investors would be aware, it's been a rough few months for the stock market. Since the start of…

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why A2 Milk, Orthocell, QBE, and Ramelius shares are pushing higher today

These shares are having a strong finish to the week. But why?

Read more »

a woman in a business suit holds a large solid gold bar in both hands with a superimposed image of a gagged gold line tracking upwards and featuring a swooping curved arrow pointing upwards.
Gold

ASX gold shares rally on another fresh record for the gold price

This corner of the market is dominating today.

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an unhappy Thursday for ASX investors.

Read more »

Delighted adult man, working on a company slogan, on his laptop.
Technology Shares

Up 38% in 2025, why this ASX 200 tech stock could surge another 39%!

A top broker expects more strong outperformance from this surging ASX 200 tech stock.

Read more »